Great Point Partners LLC Esperion Therapeutics, Inc. Transaction History
Great Point Partners LLC
- $409 Million
- Q1 2024
A detailed history of Great Point Partners LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 8,000,000 shares of ESPR stock, worth $16.7 Million. This represents 5.25% of its overall portfolio holdings.
Number of Shares
8,000,000Holding current value
$16.7 Million% of portfolio
5.25%Shares
1 transactions
Others Institutions Holding ESPR
# of Institutions
174Shares Held
125MCall Options Held
2.08MPut Options Held
1.01M-
Orbimed Advisors LLC San Diego, CA13.7MShares$28.7 Million0.83% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.94MShares$20.8 Million0.42% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT9.13MShares$19.1 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.83MShares$18.4 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA7.92MShares$16.6 Million0.2% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $139M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...